Concepedia

Scott P. Henry

SP

73

Publications

4.2K

Citations

37

H-Index

1984

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of Colorado Denver

National Jewish Health

Korea Institute of Toxicology

Scott P. Henry is an author at Ionis Pharmaceuticals (United States) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1984–2022

73

Publications

73

Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates

Frank Rigo, Seung Chun, Daniel A. Norris et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 269 citations · Full text

Activation of the Alternative Pathway of Complement by a Phosphorothioate Oligonucleotide: Potential Mechanism of Action

Scott P. Henry, Patricia C. Giclas, Michael K. Pangburn et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 203 citations

An ICAM-1 Antisense Oligonucleotide Prevents and Reverses Dextran Sulfate Sodium-Induced Colitis in Mice

C. Frank Bennett, Doug Kornbrust, Scott P. Henry et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 191 citations

Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts

Sebastien A. Burel, Christopher E. Hart, Patrick Cauntay et al. · Nucleic Acids Research · 2015 · 191 citations · Full text

, , +17

PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES

Richard S. Geary, Rosie Z. Yu, Tanya Watanabe et al. · Drug Metabolism and Disposition · 2003 · 162 citations

Rows per page

1–5 of 73